Agomelatine for the treatment of generalised anxiety disorder

Description

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Prof Sean Hood

expert

Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

Date published: 8 August 2022